Echothiophate Iodide for the Prevention of Progression of Myopia

Withdrawn before enrolling · Phase 4

Conditions studied: Myopia

In brief

The purpose of this study is to test the hypothesis that myopia progression can be slowed or prevented by low dose Echothiophate Iodide.

Key facts

Study ID

NCT02544529

Run by

Danbury Eye Physicians & Surgeons, PC

People needed

0

Starts

2016-06-01

Expected to finish

2016-06-01

Last updated by the study team

2025-02-07

Who can join

Age: 9 and older, up to 15. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy children between 8-15 years of age
• Documentation of progression of myopia within the 12 months prior to enrollment
• Written informed consent/Assent for the study

You may not qualify if…

• Any history of retinopathy of prematurity, glaucoma, cataracts, corneal disease, uveitis, manifest strabismus, nystagmus or ocular trauma
• Any history of unstable asthma, diabetes, or juvenile idiopathic arthritis Asthma must be stable for three months prior to enrollment if utilizing oral or inhaled steroids
• Systemic muscarinic agents, steroids, or anticholinesterase agents.
• Benzalkonium chloride preservative allergy.
• Astigmatism >0.75D
• Anisometropia >1.50D
• Pregnancy or a positive pregnancy test at the screening visit.

Where it is running

• Danbury Eye Physicians & Surgeons, PC — Danbury, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.